By Kate Rosenbluth
This article is an excerpt from a blog post originally published on biodesignalumni.com
Why do women rarely headline medtech conferences?
Amy Belt, Director, Covidien Ventures, pondered this question in the spring of 2009, looking out to a sea of navy blue blazers and calculating only 4% of the podium speakers at her 3 > previous conferences were women.
Belt was bothered that "it gave a visual that the experts were not woman. That simply wasn’t true." She decided to do something about it.
About the Author: Kate Rosenbluth, PhD is the 2012-2013 CTSA Stanford Biodesign Innovation Fellow. She holds a PhD in bioengineering from UCSF and UC Berkeley, with a focus on neuro-imaging and medical device design.